Serum fibroblast growth factor 23 and mineral metabolism in patients with euthyroid Graves ’ diseases: a case-control study

ConclusionSerum phosphorus and FGF23 levels remain higher in GD patients even after euthyroid status has been achieved for a median of 1.6 years. Serum FGF23 was negatively correlated with serum phosphorus in euthyroid GD patients. Underlying mechanisms warrant further investigations.Trial registrationRegistration number: NCT01660308 and NCT02620085

http://link.springer.com/10.1007/s00198-019-05116-1

Source: Osteoporosis International - August 4, 2019 Category: Orthopaedics Source Type: research